Zaporizhzhia State Medical and Pharmaceutical University

Statistics

Publications

4.8K

Citations

26.7K

Authors

131

Location

Zaporizhzhya, Ukraine

Also known as ZSMPhU · ZSMU · Universidad Estatal médico-farmacéutica de Zaporizhia · Universite médico-pharmaceutique d'État de Zaporijia · Zaporizhia State Medical University · Zaporizhia State Medical and Pharmaceutical University · Запорожки държавен медицински и фармацевтичен университет · Запорожский государственный медицинский университет · Запорізький державний медико-фармацевтичний університет · Запорізький державний медичний університет · جامعة زابوروجيا الطبية الحكومية · ज़ापोरीज्ज्या स्टेट मेडिकल यूनिवर्सिटी

Zaporizhzhia State Medical and Pharmaceutical University is a education institution in Zaporizhzhya, Ukraine known for medicine, life sciences, and cardiology.

Homepage Wikipedia ROR

Top concepts

MedicineCardiologyCardiovascular DiseasePharmacologyHeart FailureCardiac BiomarkersMedicinal ChemistryPharmacyDrug DiscoveryHeart Failure Biomarkers

Publications

4.8K

RESTORE-IMI 1: A Multicenter, Randomized, Double-blind Trial Comparing Efficacy and Safety of Imipenem/Relebactam vs Colistin Plus Imipenem in Patients With Imipenem-nonsusceptible Bacterial Infections

J. Motsch, Cláudia Murta de Oliveira, V.P. Stus et al. · Clinical Infectious Diseases · 2019 · 404 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Efficacy and safety of lixisenatide once daily vs. placebo in people with Type 2 diabetes insufficiently controlled on metformin (GetGoal‐F1)

Geremia B. Bolli, Mihnea Munteanu, S. Ya. Dotsenko et al. · Diabetic Medicine · 2013 · 142 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

UBQLN1 mediates sorafenib resistance through regulating mitochondrial biogenesis and ROS homeostasis by targeting PGC1β in hepatocellular carcinoma

Junjie Xu, Lin Ji, Yeling Ruan et al. · Signal Transduction and Targeted Therapy · 2021 · 142 citations · Full text

Life Sciences, Cell Biology, Oncology +17

Treatment of pemphigus vulgaris and foliaceus with efgartigimod, a neonatal Fc receptor inhibitor: a phase II multicentre, open‐label feasibility trial*

Matthias Goebeler, Zsuzsanna Bata‐Csörgõ, Clara De Simone et al. · British Journal of Dermatology · 2021 · 99 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +17

Pembrolizumab plus trastuzumab and chemotherapy for HER2+ metastatic gastric or gastroesophageal junction (G/GEJ) cancer: Initial findings of the global phase 3 KEYNOTE-811 study.

Yelena Y. Janjigian, Akihito Kawazoe, Patricio Yañez et al. · Journal of Clinical Oncology · 2021 · 92 citations

Medicine, Oncology, Pharmacotherapy +17

1–5 of 4.8K

Authors

131

AЕ
Alexander Е. Berezin
Zaporizhzhia State Medical and Pharmaceutical University, Ukraine
515 publications · 3.4K citations
27
h-index
AA
Alexander A. Kremzer
Zaporizhzhia State Medical and Pharmaceutical University, Ukraine
96 publications · 926 citations
18
h-index
TA
Tetiana A. Berezina
Zaporizhzhia State Medical and Pharmaceutical University, Ukraine
89 publications · 875 citations
16
h-index
YV
Yulia V. Martovitskaya
Zaporizhzhia State Medical and Pharmaceutical University, Ukraine
21 publications · 463 citations
11
h-index
NB
Nina Bukhtiyarova
Zaporizhzhia State Medical and Pharmaceutical University, Ukraine
39 publications · 368 citations
10
h-index

1–5 of 131